JAMES J. BOCHNOWSKI - 28 Mar 2022 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)

Role
Director
Signature
/s/ James J. Bochnowski
Issuer symbol
JAGX
Transactions as of
28 Mar 2022
Transactions value $
$0
Form type
4
Filing time
30 Mar 2022, 21:36:55 UTC
Previous filing
07 Jun 2021
Next filing
18 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAGX Restricted stock units Award $0 +96K $0.00 96K 28 Mar 2022 Common Stock 96K Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the issuer's 2014 Stock Incentive Plan.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock unit grants were approved by the issuer's board of directors on March 28, 2022.
F4 The restricted stock units vest in full on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice.